Background Mycoplasma genitalium is now recognised as an important bacterial sexually
transmitted infection. We summarised data from studies of mutations associated with …

Sexually transmitted infections (STIs) have been part of human life since ancient times, and
their symptoms affect quality of life, and sequelae are common. Socioeconomic and …

Background Rising macrolide and quinolone resistance in Mycoplasma genitalium
necessitate new treatment approaches. We evaluated outcomes of sequential antimicrobial …

Abstract Background Macrolide resistance in Mycoplasma genitalium (MG) exceeds 50% in
many regions, and quinolone resistance is increasing. We recently reported that resistance …

Mycoplasma genitalium is an important sexually transmitted pathogen affecting both men
and women. Its extremely slow growth in vitro and very demanding culture requirements …

Mycoplasma genitalium is one of the major causes of nongonococcal urethritis (NGU)
worldwide but an uncommon sexually transmitted infection (STI) in the general population …

This review explores the therapeutic challenges of sexually transmitted infections (STI) in
Europe, which include increasing antimicrobial resistance and limited progress in drug …

Abstract During 2016–2017, we tested asymptomatic men who have sex with men (MSM) in
Melbourne, Australia, for Mycoplasma genitalium and macrolide resistance mutations in …

Mycoplasma genitalium is a fastidious organism of the class Mollicutes, the smallest
prokaryote capable of independent replication. First isolated in 1981, much is still unknown …

Background Mycoplasma genitalium has a tendency to develop macrolide and quinolone
resistance. Objectives We investigated the microbiological cure rate of a 7 day course of …